85
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment

, , , , , , & show all
Pages 3511-3521 | Published online: 06 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Li-Chuan Tan, Wen-Jie Yang, Wei-Ping Fu, Ping Su, Jing-Kui Shu & Lu-Ming Dai. (2018) 1H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2985-2997.
Read now

Articles from other publishers (8)

Yongchun Shen, Lei Chen, Jun Chen, Jiangyue Qin, Tao Wang & Fuqiang Wen. (2022) Mitochondrial damage-associated molecular patterns in chronic obstructive pulmonary disease: Pathogenetic mechanism and therapeutic target. Journal of Translational Internal Medicine 0:0.
Crossref
Salvatore Fuschillo, Debora Paris, Annabella Tramice, Pasquale Ambrosino, Letizia Palomba, Mauro Maniscalco & Andrea Motta. (2022) Metabolomic Profiling of Exhaled Breath Condensate and Plasma/ Serum in Chronic Obstructive Pulmonary Disease. Current Medicinal Chemistry 29:14, pages 2385-2398.
Crossref
Nuria Gómez-Cebrián, Pedro Vázquez Ferreiro, Francisco Javier Carrera Hueso, José Luis Poveda Andrés, Leonor Puchades-Carrasco & Antonio Pineda-Lucena. (2021) Pharmacometabolomics by NMR in Oncology: A Systematic Review. Pharmaceuticals 14:10, pages 1015.
Crossref
Qiaoshan Tian, Ming Xu & Bei He. (2021) Histidine ameliorates elastase- and lipopolysaccharide-induced lung inflammation by inhibiting the activation of the NLRP3 inflammasome. Acta Biochimica et Biophysica Sinica 53:8, pages 1055-1064.
Crossref
Mariëlle P.K.J. Engelen, Renate Jonker, John J. Thaden, Gabriella A.M. Ten Have, Moon Sun Jeon, Srinivasan Dasarathy & Nicolaas E.P. Deutz. (2020) Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD. Clinical Nutrition 39:10, pages 3056-3065.
Crossref
Dimitris Tsoukalas, Evangelia Sarandi, Maria Thanasoula, Anca Oana Docea, Gerasimos Tsilimidos, Daniela Calina & Aristides Tsatsakis. (2019) Metabolic Fingerprint of Chronic Obstructive Lung Diseases: A New Diagnostic Perspective. Metabolites 9:12, pages 290.
Crossref
Nan Ran, Zhiqiang Pang, Yinuo Gu, He Pan, Xu Zuo, Xuewa Guan, Yuze Yuan, Ziyan Wang, Yingqiao Guo, Zixu Cui & Fang Wang. (2019) An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease. Metabolites 9:6, pages 111.
Crossref
Nilanjana Ghosh, Priyanka Choudhury, Elavarasan Subramani, Dipanjan Saha, Sayoni Sengupta, Mamata Joshi, Rintu Banerjee, Sushmita Roychowdhury, Parthasarathi Bhattacharyya & Koel Chaudhury. (2019) Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD. Metabolomics 15:6.
Crossref